Maria Grosheva1, Luisa Horstmann2, Gerd Fabian Volk3, Claudia Holler4, Laura Ludwig2, Verena Weiß5, Mira Finkensieper3, Claus Wittekindt4, Jens Peter Klussmann4, Orlando Guntinas-Lichius3, Dirk Beutner2. 1. Department of Otolaryngology, Head and Neck Surgery, University of Cologne, Kerpener Straße 62, Cologne 50937, Germany. Electronic address: maria.grosheva@uk-koeln.de. 2. Department of Otolaryngology, Head and Neck Surgery, University of Cologne, Kerpener Straße 62, Cologne 50937, Germany. 3. Department of Otolaryngology, Head and Neck Surgery, Jena University Hospital, Jena, Germany. 4. Department of Otolaryngology, Head and Neck Surgery, University of Giessen, Giessen, Germany. 5. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.
Abstract
BACKGROUND: The prevalence of Frey's syndrome (FS) after superficial parotidectomy in correlation to the sternocleidomastoid muscle flap (SCMMF) interposition is analyzed. METHODS: A prospective nonrandomized controlled multicenter trial included 130 patients. During superficial parotidectomy, SCMMF was dissected, if excised specimens' volume exceeded 25 mL (SCMMF group). Follow-up examinations took place after 6, 12, and 24 months and included a Minor's test. RESULTS: SCMMF was dissected in 30 (23.1%) patients. A total of 104, 80, and 68 patients completed the 1st, 2nd, and the 3rd follow-up, respectively. FS was detectable with nonvarying prevalence (46.3%, 45.6%, and 43.4%, respectively) during follow-up. The prevalence was higher in the SCMMF group (59.9%) than in the non-SCMMF group (41.8%; P = .92). The sweating area increased during follow-up (P = .12). Overall, 89.5% of patients characterized FS as not disturbing after 2 years. CONCLUSIONS: FS occurred with a steady and high prevalence after superficial parotidectomy. In particular, SCMMF did not lower the risk of FS.
BACKGROUND: The prevalence of Frey's syndrome (FS) after superficial parotidectomy in correlation to the sternocleidomastoid muscle flap (SCMMF) interposition is analyzed. METHODS: A prospective nonrandomized controlled multicenter trial included 130 patients. During superficial parotidectomy, SCMMF was dissected, if excised specimens' volume exceeded 25 mL (SCMMF group). Follow-up examinations took place after 6, 12, and 24 months and included a Minor's test. RESULTS:SCMMF was dissected in 30 (23.1%) patients. A total of 104, 80, and 68 patients completed the 1st, 2nd, and the 3rd follow-up, respectively. FS was detectable with nonvarying prevalence (46.3%, 45.6%, and 43.4%, respectively) during follow-up. The prevalence was higher in the SCMMF group (59.9%) than in the non-SCMMF group (41.8%; P = .92). The sweating area increased during follow-up (P = .12). Overall, 89.5% of patients characterized FS as not disturbing after 2 years. CONCLUSIONS: FS occurred with a steady and high prevalence after superficial parotidectomy. In particular, SCMMF did not lower the risk of FS.
Authors: Wenjin Wang; Yizuo Cai; Carlo M Oranges; Daniel F Kalbermatten; Dirk J Schaefer; Chuan Yang; Wei Li Journal: In Vivo Date: 2022 Jan-Feb Impact factor: 2.155
Authors: P Infante-Cossio; E Gonzalez-Cardero; A Garcia-Perla-Garcia; E Montes-Latorre; J-L Gutierrez-Perez; V-E Prats-Golczer Journal: Med Oral Patol Oral Cir Bucal Date: 2018-07-01